Table 5.
Lean-NAFLD characteristics | Controls (mean ± SD) (n = 61) |
Patients (mean ± SD) (n = 33) |
---|---|---|
Age (yr) | 32.4 ± 10.9 | 35.4 ± 8.0 |
Gender, male/female (n) | 60/1 | 35/0 |
BMI (kg/m2) | 19.7 ± 2.2 | 21.2 ± 1.5** |
Waist circumference (cm) | 77.2 ± 7.2 | 91.2 ± 8.7** |
Hip circumference (cm) | 88.2 ± 5.5 | 88.8 ± 5.2 |
Waist/hip ratio | 0.88 ± 0.06 | 1.03 ± 0.1** |
AST (IU/L) | 22.6 ± 4.8 | 85.2 ± 52.5** |
ALT (IU/L) | 20.3 ± 7.5 | 142.8 ± 71.1** |
Triglycerides (mg/dL) | 119.5 ± 61.2 | 142.8 ± 81.4 |
HDL (mg/dL) | 34.2 ± 6.8 | 37.5 ± 6.5 |
BMI: body mass index; ALT: alanine aminotransferase; AST: aspartate aminotransferase; TG: triglycerides; HDL: high-density lipoprotein; SD: standard deviation.
**P < 0.001.